<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.drugs.v2.DrugRecordOutput xmlns:ns2="local" id="84802"><DrugName>human tetanus immunoglobulin (intramuscular, tetanus), Shenzhen Weiwu Guangming Biological Products</DrugName><DrugSynonyms><Name><Value>human tetanus immunoglobulin (intramuscular, tetanus), Shenzhen Weiwu Guangming Biological Products</Value></Name></DrugSynonyms><CompanyOriginator id="1041544">Shenzhen Weiguang Biological Products Co Ltd</CompanyOriginator><CompaniesPrimary><Company id="1041544">Shenzhen Weiguang Biological Products Co Ltd</Company></CompaniesPrimary><CrossReferences><SourceEntity id="1041544" type="Company"><TargetEntity id="5000536810" type="organizationId">Shenzhen Weiguang Biological Products Co Ltd</TargetEntity></SourceEntity><SourceEntity id="72" type="ciIndication"><TargetEntity id="10043376" type="MEDDRA"></TargetEntity><TargetEntity id="D013742" type="MeSH"></TargetEntity><TargetEntity id="3299" type="ORPHANET"></TargetEntity><TargetEntity id="-687302618" type="omicsDisease"></TargetEntity><TargetEntity id="816" type="siCondition"></TargetEntity></SourceEntity><SourceEntity id="1594" type="Action"><TargetEntity id="1060" type="Mechanism">Efflux Pump (Bacterial) Inhibitors</TargetEntity><TargetEntity id="5353" type="Mechanism">Drugs Targeting Clostridium tetani Proteins</TargetEntity><TargetEntity id="4457" type="Mechanism">Drugs Targeting Staphylococcus aureus Proteins</TargetEntity><TargetEntity id="5053" type="Mechanism">Anti-Diphtheria Toxin</TargetEntity><TargetEntity id="3994" type="Mechanism">Drugs Targeting Pseudomonas aeruginosa Proteins</TargetEntity><TargetEntity id="5306" type="Mechanism">Drugs Targeting Mycobacterium tuberculosis Proteins</TargetEntity><TargetEntity id="4493" type="Mechanism">Drugs Targeting Campylobacter jejuni Proteins</TargetEntity><TargetEntity id="4563" type="Mechanism">Anti-Diphteria Toxin (Corynebacterium diphtheriae)</TargetEntity><TargetEntity id="3878" type="Mechanism">Drugs Targeting Bacterial Chaperones</TargetEntity><TargetEntity id="3697" type="Mechanism">Drugs Targeting Escherichia coli Proteins</TargetEntity><TargetEntity id="2409" type="Mechanism">Carbon Monoxide-Releasing Agents</TargetEntity></SourceEntity></CrossReferences><PhaseHighest id="L">Launched</PhaseHighest><PhaseHighestDetailed><FirstLaunched>Clostridium tetani infection - China - Dec-2005</FirstLaunched></PhaseHighestDetailed><IndicationsPrimary><Indication id="72">Clostridium tetani infection</Indication></IndicationsPrimary><ActionsSecondary><Action id="1594">Antibacterial</Action><Action id="1596">Immunomodulator</Action><Action id="59620">Unspecified drug target</Action></ActionsSecondary><Technologies><Technology id="1651">Blood constituents</Technology><Technology id="4">Immunoglobulin</Technology><Technology id="761">Biological therapeutic</Technology><Technology id="746">Solution</Technology><Technology id="651">Intramuscular formulation</Technology><Technology id="582">Antibody polyclonal</Technology></Technologies><EphmraCodes><Ephmra><Code>J1</Code><Name>SYSTEMIC ANTIBACTERIALS</Name></Ephmra></EphmraCodes><LastModificationDate>2013-09-25T15:29:57.000Z</LastModificationDate><ChangeDateLast>2013-09-25T00:00:00.000Z</ChangeDateLast><AddedDate>2013-04-29T00:00:00.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;&lt;ulink linkType="Company" linkID="1041544"&gt;Shenzhen Weiwu Guangming Biological Products&lt;/ulink&gt; has developed and launched a plasma-derived human tetanus immunoglobulin, for the im treatment or prevention of tetanus. This product was assumed to be launched in China shortly after its approval there in 2005 [&lt;ulink linkType="Reference" linkID="1410682"&gt;1410682&lt;/ulink&gt;], [&lt;ulink linkType="Reference" linkID="1409381"&gt;1409381&lt;/ulink&gt;].&lt;/para&gt;&lt;/Summary&gt;</value></Summary></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="1041544">Shenzhen Weiguang Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate xmlns:ns3="http://serviceversion" xmlns:ns2="http://v2.drugs.soap.contract.service.ls.thomsonreuters.com/">2005-12-31T00:00:00.000Z</StatusDate><Source id="1409381" type="CORPORATE"></Source></DevelopmentStatusCurrent><DevelopmentStatusHistoric><Company id="1041544">Shenzhen Weiguang Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="72">Clostridium tetani infection</Indication><StatusDate xmlns:ns3="http://serviceversion" xmlns:ns2="http://v2.drugs.soap.contract.service.ls.thomsonreuters.com/">2005-12-31T00:00:00.000Z</StatusDate><Source id="1410682" type="OTHER"></Source></DevelopmentStatusHistoric></IDdbDevelopmentStatus><ReasonsForUpdate><ReasonForUpdate><Reason>Indexing Updated</Reason><Description>Indexing updated</Description></ReasonForUpdate></ReasonsForUpdate><hasSWOTs>N</hasSWOTs></ns2:com.thomsonreuters.ls.service.contract.soap.drugs.v2.DrugRecordOutput>